Analysis of Treatment Option for Synchronous Liver Metastases and Colon Rectal Cancer

Danilo Coco and Silvana Leanza

Department of General Surgery and Surgical Pathology, Ospedali Riuniti Marche Nord, Italy
Department of General Surgery and Surgical Pathology, Carlo Urbani Hospital Jesi, Italy

^*Correspondance to: Danilo Coco 

 PDF  Full Text DOI: 10.25107/2474-1647.2444

Abstract

Colorectal or bowel cancer is one of the major causes of cancer worldwide. Research has shown that 15% to 20% colorectal cancer patients are also diagnosed with synchronous Liver Metastases (LM) at presentation and about one third eventually develop liver lesions. Management of cases with colorectal cancer comorbid with liver metastases is more complex. This highlights the need for suggesting the need for effective treatment while optimizing timing during surgical and medical treatment of primary plus metastatic disease. Such patients cases are likely to present with severe cancer biology and thereby less likely to be long-term survivors.

Keywords

Cite the article

Coco D, Leanza S. Analysis of Treatment Option for SynchronousLiver Metastases and Colon RectalCancer. Clin Surg. 2019; 4: 2444.